离子独立的曼诺6酸盐受体:从角色和功能到向治疗
Corentin Gauthier1, Khaled El Cheikh2, Ilaria Basile2
1NanoMedSyn, Montpellier, France; IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
概括
阴离子独立的曼诺6酸盐受体 (CI-M6PR) 将酶引导到 lysosomes. 这种受体通过向细胞内化和降解途径,显示出对疾病的治疗潜力.
科学领域:
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
- 生物化学 生物化学
背景情况:
- 离子独立的曼诺6酸盐受体 (CI-M6PR) 对于溶酶酶的向至关重要.
- 新出现的证据将CI-M6PR与各种病理生理过程联系起来.
- 它的跨膜部分在细胞功能中起着重要作用.
研究的目的:
- 审查CI-M6PR的连接体合作伙伴和多种角色.
- 探索CI-M6PR在溶酶体储存疾病,神经学,免疫学和癌症中的参与.
- 突出CI-M6PR的治疗潜力.
主要方法:
- 对CI-M6PR功能和应用的文献综述.
- 分析CI-M6PR在不同疾病模型中的作用.
- 使用CI-M6PR.治疗策略的评估.
主要成果:
- CI-M6PR与各种连接体合作伙伴相互作用.
- CI-M6PR与溶酶体储存疾病,神经系统疾病,免疫反应和癌症进展有关.
- 该受体的内部化和溶酶体向能力得到证实.
结论:
- CI-M6PR是一种具有重要病理生理学作用的多功能受体.
- 它的独特特性提供了有前途的治疗途径.
- 使用CI-M6PR的输送系统,包括酶,抗体和纳米粒子,正在开发针对性疗法.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Carrier-Mediated Transport
441
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
441
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Amplifying Signals via Second Messengers
7.0K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.0K


